Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

3.22.118.57
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Journal Scan
Oncology

How does treatment at a high-volume institution impact overall survival in STS?

Posted on

No significant association between socioeconomic factors and overall survival (OS) was found in patients with soft tissue sarcoma (STS) treated at a high-volume institution, according to a retrospective analysis at a single institution.

-Advertisement-
-Advertisement-

Of the 435 patients included, 37% had grade 3 tumors, 44% had disease >5 cm, and 38% were privately insured. More than half (52%) of patients received neoadjuvant therapy prior to resection.
According to the study, “median distance from the treatment center was 42 miles and median area deprivation index (ADI) was 5 (10 representing most deprived communities).”
Multivariate analysis found that higher tumor grade, tumor size >5 cm, and involved lymph nodes were significantly associated with OS.

The following factors were not found to be associated with OS:
Sex
Age at diagnosis
Marital status
Employment status
Urban vs. rural location
Income
Education
Distance to the treatment center
ADI

“Treatment at a high-volume institution may mitigate the importance of socio-economic factors in the OS of STS,” the authors concluded.

Reference
Eastman BM, Hippe DS, Wootton LS, et al. Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume center. BMC Cancer. 2021;21(1):620. doi: 10.1186/s12885-021-08352-z. PMID: 34039294.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-